Drug recall · July 20, 2016
Duloxetine Delayed-Release Capsules recall
Why: Failed Dissolution Specification: Out of specification dissolution results when testing product stability.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Duloxetine Delayed-Release Capsules, USP, 20 mg, 60-count bottles, Rx only, Manufactured by Apotex Inc, Toronto, Ontario M9L 1T9, Manufactured for Apotex Corp. Weston Florida 33326, NDC 60505-2995-6; UPC # 360505299560;
- Lots / codes
Lot #: KV9795, KV9794, KV9796, KX6278; Exp 04/30/2016.
- Quantity
- 107,880 (60 ct bottle)
- Company
- Apotex Scientific, Inc, Arlington, TX
- Distribution
- Nationwide, Alaska, Hawaii, and Puerto Rico.
- Initiated
- January 26, 2016 · Voluntary: Firm initiated
- Classified
- July 14, 2016
- Reported
- July 20, 2016
- Ended
- June 15, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Duloxetine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.